Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Quinn

Showing results (531-540 of 635) with videos related to

Pageof 64
Sort By:
Theranostics|January 7, 2020
Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effectJeroen A C M Goos, Andrew Cho, Lukas M Carter, et al.
Molecular & Cellular Proteomics : MCP|January 4, 2015
Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validationMin Shi, James Movius, Romel Dator, et al.
Proteomics. Clinical Applications|March 21, 2017
An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progressionLi Yang, Tessandra Stewart, Min Shi, et al.
Biomaterials|May 2, 2022
Aerosol delivery of star polymer-siRNA nanoparticles as a therapeutic strategy to inhibit lung tumor growthZ Ma, S W Wong, H Forgham, et al.
Biomacromolecules|October 17, 2017
Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid AggregationEmily H Pilkington, May Lai, Xinwei Ge, et al.
Neurology|March 1, 2006
Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer diseaseE R Siemers, J F Quinn, J Kaye, et al.
Frontiers in Neuroscience|September 28, 2021
Cerebrospinal Fluid MicroRNA Changes in Cognitively Normal Veterans With a History of Deployment-Associated Mild Traumatic Brain InjuryTheresa A Lusardi, Ursula S Sandau, Nikita A Sakhanenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumorsPatricia M Lorusso, Martin J Edelman, Susan L Bever, et al.
Journal of Parkinson'S Disease|August 14, 2013
Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristicsBrenna A Cholerton, Cyrus P Zabetian, Joseph F Quinn, et al.
Alzheimer'S Research & Therapy|July 5, 2017
Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adultsGe Li, Jane B Shofer, Eric C Petrie, et al.
Pageof 64

Showing results (531-540 of 635) with videos related to

Sort By:
Pageof 64
Theranostics|January 7, 2020
Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effectJeroen A C M Goos, Andrew Cho, Lukas M Carter, et al.
Molecular & Cellular Proteomics : MCP|January 4, 2015
Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validationMin Shi, James Movius, Romel Dator, et al.
Proteomics. Clinical Applications|March 21, 2017
An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progressionLi Yang, Tessandra Stewart, Min Shi, et al.
Biomaterials|May 2, 2022
Aerosol delivery of star polymer-siRNA nanoparticles as a therapeutic strategy to inhibit lung tumor growthZ Ma, S W Wong, H Forgham, et al.
Biomacromolecules|October 17, 2017
Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid AggregationEmily H Pilkington, May Lai, Xinwei Ge, et al.
Neurology|March 1, 2006
Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer diseaseE R Siemers, J F Quinn, J Kaye, et al.
Frontiers in Neuroscience|September 28, 2021
Cerebrospinal Fluid MicroRNA Changes in Cognitively Normal Veterans With a History of Deployment-Associated Mild Traumatic Brain InjuryTheresa A Lusardi, Ursula S Sandau, Nikita A Sakhanenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumorsPatricia M Lorusso, Martin J Edelman, Susan L Bever, et al.
Journal of Parkinson'S Disease|August 14, 2013
Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristicsBrenna A Cholerton, Cyrus P Zabetian, Joseph F Quinn, et al.
Alzheimer'S Research & Therapy|July 5, 2017
Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adultsGe Li, Jane B Shofer, Eric C Petrie, et al.
Pageof 64